Warfarin Sodium Tablets Usp 5MG


Indications and Reactions:

Role Indications Reactions
Primary
Atrial Fibrillation 43.1%
Pulmonary Embolism 26.4%
Cerebrovascular Accident 8.3%
Deep Vein Thrombosis 5.6%
Thrombectomy 4.2%
Blood Cholesterol 2.8%
Pulmonary Oedema 2.8%
Back Pain 1.4%
Blood Cholesterol Increased 1.4%
Cystitis 1.4%
Dermatomyositis 1.4%
Neuropathy Peripheral 1.4%
International Normalised Ratio Increased 14.3%
Product Quality Issue 12.2%
International Normalised Ratio Decreased 10.2%
Blood Pressure Increased 8.2%
Product Substitution Issue 8.2%
Alopecia 6.1%
International Normalised Ratio Fluctuation 6.1%
Rash 6.1%
Visual Impairment 6.1%
Contusion 2.0%
Drug Ineffective 2.0%
Food Allergy 2.0%
Local Swelling 2.0%
Mitral Valve Disease 2.0%
Necrosis 2.0%
Neuropathy Peripheral 2.0%
Pain 2.0%
Protein Total Decreased 2.0%
Pruritus 2.0%
Pulmonary Embolism 2.0%
Secondary
Atrial Fibrillation 28.7%
Deep Vein Thrombosis 19.0%
Pulmonary Embolism 18.3%
Thrombectomy 8.3%
Cerebrovascular Accident 8.0%
Aortic Valve Replacement 6.2%
Transient Ischaemic Attack 5.5%
Palpitations 2.1%
Back Pain 1.4%
Blood Cholesterol 1.4%
Pulmonary Oedema 0.7%
Dermatomyositis 0.3%
Product Quality Issue 19.5%
Thrombosis 17.2%
International Normalised Ratio Increased 11.7%
Product Substitution Issue 10.9%
International Normalised Ratio Decreased 9.4%
International Normalised Ratio Fluctuation 4.7%
Mitral Valve Disease 3.9%
Tobacco Poisoning 3.1%
International Normalised Ratio Abnormal 2.3%
Migraine 2.3%
Pulmonary Thrombosis 2.3%
Stent Placement 2.3%
Necrosis 1.6%
Palpitations 1.6%
Rash 1.6%
Visual Impairment 1.6%
Vulvitis 1.6%
Alopecia 0.8%
Drug Ineffective 0.8%
Pulmonary Embolism 0.8%

Drug Data